Drug Search Results
More Filters [+]

CECT-5713

Alternative Names: cect-5713, cect5713, cect 5713
Latest Update: 2024-03-04
Latest Update Note: Clinical Trial Update

Product Description

Lactobacillus salivarius CECT5713 isolated from breast milk

Mechanisms of Action: Unknown

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Puleva Biotech
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for CECT-5713

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 2: Infertility|Abortion, Spontaneous

Phase 1: Vision, Low

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

PROBIFERT P051

N/A

Completed

Infertility

2023-05-03

PROBIFERT P051

N/A

Active, not recruiting

Abortion, Spontaneous|Infertility

2023-05-03

PREPROBIFERT01

P2

Completed

Infertility|Abortion, Spontaneous

2019-11-29

P010

P1

Completed

Vision, Low

2007-09-01

Recent News Events